biopharmaceutical company in Germany
Multi-million euro offer for plant in Tübingen: 500 CureVac employees to be taken on
swp.de/lokales/tuebingen/millionenangebot-fuer-werk-in-tuebingen-500-mitarbeiter-von-curevac-sollten-uebernommen-werden-79573804.html
Low demand for coronavirus vaccine: CureVac in Tübingen facing closure: The BioNTech site at the former CureVac headquarters in Tübingen is being closed ...
swr.de/swraktuell/baden-wuerttemberg/tuebingen/curevac-tuebingen-aus-100.html
Key FactsBiontech announces closure of three sites from 2027
Sep 29, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: handelsblatt.com
Summary created with AI assistance · Source: handelsblatt.com
- The closures are scheduled for Tübingen in late 2027, Marburg in early 2028 and Idar-Oberstein in late 2028.
- According to the company, the decision affects about 1,800 employees, nearly one-quarter of Biontech’s workforce.
- Biontech attributed the failed months-long search mainly to difficult market and investment conditions.
- Biontech agreed additional severance terms with the group works council, but initially disclosed no details.
The company is researching novel immunotherapies. The aim is for white blood cells to soon be able to fight cancer cells. However ... Show more
Hope for the sick and the economy: Is Immatics' cancer research on the verge of a major breakthrough?
Hope for the sick and the economy: Is Immatics' cancer research on the verge of a major breakthrough?
Tübingen biotech company: Immatics is researching cancer therapy - | but CureVac's demise was a "shock"
stuttgarter-zeitung.de/lokales/baden-wuerttemberg/tuebinger-biotech-unternehmen-immatics-die-nachricht-war-fuer-uns-ein-schock-79573500.html
Paid articlePaywall
Exclusive: The BioNTech closures leave the German government in Berlin unmoved: Until now, it was unknown how the German government felt about the BioNTech ...
gnz.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/exklusiv-biontech-schliessungen-lassen-bundesregierung-kalt-6551836
Paid articlePaywallOpinionAfter CureVac's exit in Tübingen: What is the state government's CureVac task force actually doing?
swp.de/lokales/tuebingen/nach-curevac-aus-in-tuebingen-was-macht-eigentlich-die-curevac-taskforce-der-landesregierung-79521574.html
Paid articlePaywallStart-up Arife: Özdemir wants to lure the new company of the Biontech founders to Tübingen
swp.de/baden-wuerttemberg/start-up-arife-oezdemir-will-neue-firma-von-biontech-gruenderpaar-nach-tuebingen-locken-79514718.html
Paid articlePaywallWorks council on failed sale plans: There is no more hope for CureVac: BioNTech's sale plans have fallen through: CureVac will be permanently closed at the ...
swp.de/lokales/tuebingen/betriebsrat-zu-gescheiterten-verkaufsplaenen-fuer-curevac-gibt-es-keine-hoffnung-mehr-79509926.html
Paid articlePaywall 😔 "You feel abandoned, betrayed." For the approximately 440 employees of BioNTech in Idar-Oberstein, the last hope for a future for the site has been dashed ... Show more
OpinionMillion-dollar bonuses: Boris Palmer rants: Payments to CureVac manager "outrageous"
stuttgarter-nachrichten.de/wirtschaft/millionen-boni-boris-palmer-empoerend-hohe-zahlungen-an-curevac-manager-79539819.html
"That's impossible": BioNTech breaks promises - | 1,800 people lose their jobs in Germany
op-online.de/wirtschaft/biontech-schliesst-drei-standorte-1800-jobs-weg-kein-kaeufer-gefunden-zr-94518629.html
Medical technology in the Southwest: End for CureVac - | not for Tübingen: The medium-sized companies in the Southwest bravely continue. And they are investing ...
stuttgarter-nachrichten.de/wirtschaft/medizintechnik-im-suedwesten-aus-fuer-curevac-nicht-fuer-tuebingen-79513846.html
Paid articlePaywall
Exclusive: Federal government wants to sell all BioNTech shares it holds: Since BioNTech acquired CureVac, the German government has held shares in the ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/exklusiv-bundesregierung-stoesst-alle-biontech-aktien-ab-6476398
Paid articlePaywall“Business meets municipality” in Tübingen: Palmer on CureVac: “The die is not yet cast”
swp.de/lokales/tuebingen/wirtschaft-trifft-kommune-in-tuebingen-palmer-zu-curevac-die-messe-ist-noch-nicht-gelesen-79453614.html
Paid articlePaywall
CureVac in Tübingen: Takeover by BioNTech and sites in danger: BioNTech acquired CureVac for $1.25 billion at the end of last year and will now close all CureVac ...
sueddeutsche.de/wirtschaft/ugur-sahin-oezlem-tuereci-ingmar-hoerr-struengmann-mrna-impfstoffe-mrna-krebs-moderna-li.3522088
Paid articlePaywallWill the Tübingen site be completely closed?: Clarity on BioNTech locations by the end of September
swp.de/lokales/tuebingen/tuebinger-standort-bedroht-klarheit-ueber-biontech-standorte-bis-ende-september-79418978.html
OpinionMedizin und Arbeitsplätze in Tübingen: Heilsam – die Erfolgsstory von Erbe wirkt wie Balsam nach dem Curevac-Trauma
swp.de/lokales/tuebingen/medizin-und-arbeitsplaetze-in-tuebingen-heilsam-die-erfolgsstory-von-erbe-wirkt-wie-balsam-nach-dem-curevac-trauma-79301147.html
Paid articlePaywall
Takeover: How managers maintain productivity despite a takeover: A threatened takeover causes confusion among the workforce and jeopardizes the business ...
wiwo.de/erfolg/management/uebernahme-wie-fuehrungskraefte-die-produktivitaet-trotz-uebernahme-hochhalten/100235761.html
CureVac and BioNTech in Tübingen: These were the promises for the CureVac location in Tübingen back in 2025
swp.de/lokales/tuebingen/curevac-und-biontech-in-tuebingen-das-waren-noch-2025-die-versprechungen-fuer-den-curevac-standort-tuebingen-79108233.html
Paid articlePaywall
BioNTech closes CureVac site in Tübingen: What happened to 300 million euros of taxpayers' money
op-online.de/wirtschaft/curevac-und-biontech-wie-der-impfstoff-traum-der-merkel-aera-endet-zr-94355314.html
BioNTech plans to close plant with 750 employees - | despite share deal with government
businessinsider.de/wirtschaft/biontech-will-werk-mit-750-mitarbeitern-schliessen-trotz-aktien-deal-mit-regierung/
Paid articlePaywall 
Key FactsBiontech Focuses on Cancer, Cuts Nearly 2000 Jobs
May 5, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: faz.net
Summary created with AI assistance · Source: faz.net
- Biontech will cease production of its COVID-19 vaccine Comirnaty and transfer manufacturing entirely to Pfizer.
- The company is prioritizing cancer drug research, investing €557 million in R&D during Q1 2026.
- Production facilities in Idar-Oberstein, Marburg, Singapore, and Curevac sites will close by the end of 2027, affecting 1860 employees.
- Cost savings are expected to reach €500 million yearly to support commercialization of its oncology product pipeline.
For many Biontech employees, a future vision is currently being dashed— IGBCE, represented by Roland Strasser, head of the IGBCE regional district Rhineland-Palatinate-Saarland
After CureVac's exit from Tübingen: Mayor Palmer and BioNTech are exploring solutions to preserve the site
swp.de/lokales/tuebingen/nach-curevac-aus-in-tuebingen-ob-palmer-und-biontech-pruefen-loesungen-fuer-erhalt-des-standorts-79076630.html
BioNTech plans Wiesbaden site closure: Future of CureVac jobs uncertain: Since the beginning of May, not only BioNTech employees but also CureVac employees have ...
wiesbadener-kurier.de/lokales/wiesbaden/stadt-wiesbaden/sorge-um-die-zukunft-der-wiesbadener-curevac-beschaeftigten-5714365
Paid articlePaywall
Union: The mask has fallen at BioNTech: There is great uncertainty among the employees: Are there potential buyers for the plants? Can jobs be saved?
giessener-allgemeine.de/wirtschaft/gewerkschaft-bei-biontech-ist-die-maske-gefallen-zr-94319617.html
Drama surrounding CureVac in Tübingen: "Trust damaged": Tübingen local politicians sharply criticize BioNTech
swp.de/lokales/tuebingen/drama-um-curevac-in-tuebingen-vertrauen-beschaedigt-tuebinger-lokalpolitiker-kritisieren-biontech-scharf-79064508.html
Paid articlePaywall After Curevac exit—Biontech co-founder pledges support to affected employees: Following the end of the COVID-19 pandemic, Biontech is refocusing on the ...
stuttgarter-nachrichten.de/inhalt.nach-curevac-aus-biontech-mitbegruender-sichert-betroffenen-mitarbeitern-unterstuetzung-zu.b6dd294c-13f1-4971-8141-1a9521f59533.html
After CureVac exit: BioNTech returns to its roots: Following the end of the coronavirus pandemic, BioNTech's focus has returned to the research and ...
rheinpfalz.de/startseite_artikel,-nach-curevac-aus-biontech-kehrt-zu-seinen-wurzeln-zur%C3%BCck-_arid,5890588.html
Biotech Earthquake in Tübingen: "Soulless, brazen, total catastrophe" - | CureVac Specialist Offers Insights
swp.de/lokales/tuebingen/biotech-beben-in-tuebingen-seelenlos-dreist-totale-katastrophe-curevac-spezialist-im-interview-79063934.html
Paid articlePaywall Following the announced closure of the CureVac site, Dievini CEO Mathias Hothum also speaks of a loss for Germany as a research location ... Show more
Heidelberg: Hopp has to accept Biontech decision
Heidelberg: Hopp has to accept Biontech decision
Stirring around Biontech and Curevac – biotech firms in Tübingen aren’t running out of steam
stuttgarter-nachrichten.de/inhalt.wirbel-um-biontech-und-curevac-biofirmen-in-tuebingen-geht-die-puste-nicht-aus.b1a93e4e-f1d7-4665-a276-748a405b7a92.html
Key FactsTübingen’s Biotech Sector Adapts Beyond Curevac
May 11, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: stuttgarter-nachrichten.de
Summary created with AI assistance · Source: stuttgarter-nachrichten.de
- Cegat anticipates increased revenues in 2026 and considers expanding its site, currently employing 220 people.
- Intavis projects significant sales growth and may build a new technology facility on available land.
- Immatics employs about 300 staff in Tübingen and is funded through venture capital and partnerships without market revenues.
- Several companies like Cegat, HB Technologies, and Immatics seek skilled professionals, including former Curevac employees.
But you can't absorb 780 employees all at once in Tübingen.— Thorsten Flink, managing director of the city's economic development company, on the potential transfer of Curevac employees.
Pharmaceuticals: Works council fights for BioNTech jobs and locations: Can an investor save the almost 1,900 jobs? Talks about the future of the sites are ...
swp.de/lokales/tuebingen/pharma-betriebsrat-kaempft-um-jobs-und-standorte-von-biontech-79057268.html
Biotech exit in Tübingen: CureVac: Who are the over 700 people in the Tübingen technology park?
swp.de/lokales/tuebingen/biotech-aus-in-tuebingen-curevac-wer-sind-die-ueber-700-leute-im-tuebinger-technologiepark-78849010.html
Paid articlePaywall
BioNTech plans site closures: CureVac founder Ingmar Hoerr criticizes deception.: BioNTech plans to close several locations. The CureVac founder and the union ...
faz.net/aktuell/wirtschaft/biontech-plant-standortschliessungen-curevac-gruender-ingmar-hoerr-kritisiert-taeuschung-200804035.html
Pharmaceutical industry: CureVac founder accuses BioNTech of deception: Shortly after the acquisition, BioNTech announced the closure of CureVac's former ...
zeit.de/wirtschaft/unternehmen/2026-05/curevec-gruender-vorwurf-taeuschung-biontech
Why Germany ranks last in clinical trials: Despite being world-class in basic research, most new therapies fail. Clinical trials are extremely complicated in ...
fr.de/wissen/warum-deutschland-bei-klinischen-studien-auf-den-letzten-plaetzen-landet-94152988.html
Bayer Group surprisingly sues Mainz-based BioNTech - | here's the background: No sooner has the patent dispute with CureVac been settled through the takeover ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/bayer-verklagt-ueberraschend-biontech-was-ist-da-los-5297243
Paid articlePaywall
📊 PreMarket Movers – January 2, 2026
📈 Gainers:
⬆️ $SMX +37.12%
⬆️ $SOC +22.61%
⬆️ $SIDU +21.33%
📉 Losers:
⬇️ $ANGH -3.72%
⬇️ $CVAC -1.11%
⬇️ $HLN -1.09%
BioNTech, CureVac, cancer: the status of Marburg's Görzhausen industrial park
op-marburg.de/lokales/marburg-biedenkopf/marburg/biontech-curevac-krebs-der-stand-bei-marburgs-goerzhausen-gewerbegebiet-E3QRNTDQC5FCHF3BHBH2IMNK2Q.html
Paid articlePaywall
BioNTech stock: Hope is back: BioNTech acquires CureVac and strengthens market position; blockbuster potential for new cancer drug BNT327.
boerse-online.de/nachrichten/aktien/biontech-aktie-die-hoffnung-ist-zurueck-20392023.html
Biotechnology company - | CureVac takeover by BioNTech will be completed in January
stuttgarter-nachrichten.de/inhalt.biotechnologie-unternehmen-curevac-uebernahme-durch-biontech-wird-im-januar-vollendet.eae68d7c-2e9b-43e9-b996-546fad6ef3b1.html
80 percent of shares acquired: CureVac billion-euro deal with BioNTech close to completion
swp.de/lokales/tuebingen/80-prozent-der-aktien-uebernommen-curevac-milliarden-deal-mit-biontech-kurz-vor-abschluss-78493611.html
Positive one-off effect: Tübingen-based company CureVac reports high profit - | Business News - | Reutlinger General-Anzeiger - | gea.de
gea.de/neckar-alb/wirtschaft-in-der-region_artikel,-positiver-einmaleffekt-t%C3%BCbinger-unternehmencurevac-weist-hohen-gewinn-aus-_arid,7098040.html
Share swap - | Biontech launches offer to Curevac shareholders: The deadline for the share swap is December 3rd. The former competitors plan to conduct joint ...
stuttgarter-nachrichten.de/inhalt.aktientausch-biontech-startet-angebot-an-curevac-aktionaere.9753c233-bf64-4877-8fed-36fe7b77f02d.html
Mainz pharmaceutical company - | Cartel office allows Biontech to buy Curevac: Why do the competition authorities see no threat to innovation in the merger ...
stuttgarter-nachrichten.de/inhalt.mainzer-pharmaunternehmen-kartellamt-erlaubt-kauf-von-curevac-durch-biontech.a447a0e2-53e5-468b-a613-3ee1d006a805.html
Biontech from Mainz makes a takeover offer to Curevac shareholders: In June, the vaccine company, which also produces in Marburg, announced the takeover of its ...
op-marburg.de/lokales/marburg-biedenkopf/marburg/biontech-aus-mainz-macht-curevac-aktionaeren-ein-uebernahme-angebot-PUA2FFREAFDALK5VYKDMFWVWUA.html
Paid articlePaywall
Curevac founder Ingmar Hoerr: “It's certain that a new virus is coming.”: Ingmar Hoerr was at the forefront of the race for a coronavirus vaccine with Curevac ...
augsburger-allgemeine.de/wirtschaft/curevac-gruender-ingmar-hoerr-es-ist-sicher-dass-ein-neues-virus-kommt-112591724
Biontech and Tübingen-based company Curevac end patent dispute - | State of Baden-Württemberg - | Reutlinger General-Anzeiger - | gea.de
gea.de/land_artikel,-biontech-und-t%C3%BCbinger-unternehmen-curevac-beenden-patentstreit-_arid,7060048.html
